Listing 3 - Actual negotiations

Indication:

Renal cell carcinoma (RCC), for adjuvant treatment of adult patients, at intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection of metastatic lesions

Indication:

Myasthenia Gravis

Indication:

Neuromyelitis optica spectrum disorder (NMOSD)

Indication:

Psoriasis, moderate to severe plaque

Indication:

Growth hormone deficiency

Indication:

Unresectable, locally advanced or metastatic urothelial cancer in adult patients who have previously received a platinum-containing chemotherapy and programmed death receptor-1 or programmed death-ligand 1 inhibitor therapy

Indication:

Migraine, prevention

Indication:

Spinal Muscular Atrophy in adult patients over 18 years of age

Indication:

Diabetes Mellitus, Type 1 & 2

Indication:

Mild to moderate essential hypertension and management of chronic stable angina